Toward personalization of asthma treatment according to trigger factors.
Asthma
allergen
allergy
microarray
rhinovirus
wheeze
Journal
The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
17
12
2019
revised:
06
02
2020
accepted:
07
02
2020
pubmed:
23
2
2020
medline:
20
2
2021
entrez:
22
2
2020
Statut:
ppublish
Résumé
Asthma is a severe and chronic disabling disease affecting more than 300 million people worldwide. Although in the past few drugs for the treatment of asthma were available, new treatment options are currently emerging, which appear to be highly effective in certain subgroups of patients. Accordingly, there is a need for biomarkers that allow selection of patients for refined and personalized treatment strategies. Recently, serological chip tests based on microarrayed allergen molecules and peptides derived from the most common rhinovirus strains have been developed, which may discriminate 2 of the most common forms of asthma, that is, allergen- and virus-triggered asthma. In this perspective, we argue that classification of patients with asthma according to these common trigger factors may open new possibilities for personalized management of asthma.
Identifiants
pubmed: 32081759
pii: S0091-6749(20)30193-7
doi: 10.1016/j.jaci.2020.02.001
pmc: PMC7613502
mid: EMS153503
pii:
doi:
Substances chimiques
Allergens
0
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1529-1534Subventions
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K002449/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S025340/1
Pays : United Kingdom
Organisme : Austrian Science Fund FWF
ID : P 29398
Pays : Austria
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Références
EBioMedicine. 2017 Dec;26:91-99
pubmed: 29221963
Clin Exp Allergy. 2008 Oct;38(10):1615-26
pubmed: 18647315
Am J Respir Crit Care Med. 2012 Feb 1;185(3):281-5
pubmed: 21960534
FASEB J. 2012 Mar;26(3):1001-8
pubmed: 22121050
Eur Respir J. 2000 Nov;16(5):802-7
pubmed: 11153575
Viruses. 2019 Mar 04;11(3):
pubmed: 30836639
BMJ. 2002 Mar 30;324(7340):763
pubmed: 11923159
N Engl J Med. 1995 Jan 19;332(3):133-8
pubmed: 7800004
Pediatr Clin North Am. 2019 Oct;66(5):967-979
pubmed: 31466685
Allergy. 2019 Sep;74(9):1649-1659
pubmed: 30865306
Pediatr Allergy Immunol. 2015 May;26(3):239-246
pubmed: 25720596
Lancet. 2006 Aug 26;368(9537):763-70
pubmed: 16935687
Nat Med. 2012 May 04;18(5):726-35
pubmed: 22561836
J Occup Environ Hyg. 2020 Jan;17(1):30-37
pubmed: 31855526
J Thorac Dis. 2018 Mar;10(3):2059-2069
pubmed: 29707364
Front Pediatr. 2017 May 10;5:103
pubmed: 28540285
Eur Respir J. 2016 Jan;47(1):304-19
pubmed: 26677936
Eur Respir J. 2019 Nov 28;54(5):
pubmed: 31515404
Expert Rev Clin Immunol. 2019 Sep;15(9):951-958
pubmed: 31389304
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):654-60
pubmed: 8810601
Nat Commun. 2018 Jun 18;9(1):2382
pubmed: 29915220
Lancet. 2008 Sep 20;372(9643):1100-6
pubmed: 18805338
Sci Rep. 2018 Jun 26;8(1):9688
pubmed: 29946071
EBioMedicine. 2017 Mar;17:16-17
pubmed: 28259589
EBioMedicine. 2016 Sep;11:43-57
pubmed: 27650868
Lancet Respir Med. 2018 Jul;6(7):526-534
pubmed: 29628377
Methods. 2014 Mar 1;66(1):106-19
pubmed: 24161540
World Allergy Organ J. 2018 Jun 26;11(1):13
pubmed: 29988331
Lancet. 2013 Mar 9;381(9869):861-73
pubmed: 23428115
Pediatr Allergy Immunol. 2018 Jun;29(4):383-393
pubmed: 29512854
Allergy Asthma Proc. 2016 Nov;37(6):475-481
pubmed: 27931303
J Allergy Clin Immunol. 2012 Jun;129(6):1499-1505.e5
pubmed: 22560151
Allergy. 2017 Dec;72(12):1825-1848
pubmed: 28543086
EBioMedicine. 2014 Nov 18;2(1):64-70
pubmed: 26137535
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1490-1499
pubmed: 30134114